UNI HEALTH (02211) announced its annual results for the year ended June 30, 2025, reporting revenue of approximately HK$711.5 million, a decrease of 34.7% year-on-year. Gross profit reached approximately HK$113.4 million, down 37% compared to the previous year. The company recorded a loss attributable to owners of HK$26.006 million, representing a turn from profit to loss year-on-year, with a loss per share of 32.46 cents. The announcement attributed the revenue decline primarily to the impact of China's new medical insurance policies and a decrease in the number of active customers within the national distribution network.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments